Synopsys, Inc. $SNPS Stock Holdings Boosted by Norinchukin Bank The

Norinchukin Bank The lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 46.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 16,826 shares of the semiconductor company’s stock after acquiring an additional 5,371 shares during the period. Norinchukin Bank The’s holdings in Synopsys were worth $7,216,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Williams Jones Wealth Management LLC. lifted its position in shares of Synopsys by 0.5% in the fourth quarter. Williams Jones Wealth Management LLC. now owns 4,650 shares of the semiconductor company’s stock worth $2,257,000 after purchasing an additional 22 shares in the last quarter. Hardy Reed LLC lifted its position in shares of Synopsys by 0.7% in the first quarter. Hardy Reed LLC now owns 3,290 shares of the semiconductor company’s stock worth $1,411,000 after purchasing an additional 22 shares in the last quarter. Resurgent Financial Advisors LLC lifted its position in shares of Synopsys by 2.7% in the first quarter. Resurgent Financial Advisors LLC now owns 832 shares of the semiconductor company’s stock worth $357,000 after purchasing an additional 22 shares in the last quarter. Trust Asset Management LLC lifted its position in shares of Synopsys by 1.3% in the first quarter. Trust Asset Management LLC now owns 1,766 shares of the semiconductor company’s stock worth $757,000 after purchasing an additional 22 shares in the last quarter. Finally, Harbour Investments Inc. lifted its position in shares of Synopsys by 10.8% in the first quarter. Harbour Investments Inc. now owns 235 shares of the semiconductor company’s stock worth $101,000 after purchasing an additional 23 shares in the last quarter. Institutional investors own 85.47% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on SNPS shares. The Goldman Sachs Group started coverage on Synopsys in a report on Thursday, July 10th. They issued a “buy” rating and a $620.00 price objective on the stock. Needham & Company LLC restated a “buy” rating and issued a $660.00 price objective (up previously from $650.00) on shares of Synopsys in a report on Tuesday, July 15th. Piper Sandler increased their price objective on Synopsys from $615.00 to $660.00 and gave the stock an “overweight” rating in a report on Monday, July 21st. Bank of America increased their price objective on Synopsys from $575.00 to $625.00 and gave the stock a “buy” rating in a report on Wednesday, July 16th. Finally, Morgan Stanley restated an “overweight” rating and issued a $715.00 price objective (up previously from $540.00) on shares of Synopsys in a report on Monday, August 11th. Twelve analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and a consensus price target of $626.79.

Insider Activity

In related news, CRO Richard S. Mahoney sold 9,010 shares of the firm’s stock in a transaction on Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total value of $4,245,602.10. Following the completion of the transaction, the executive directly owned 1,485 shares of the company’s stock, valued at $699,746.85. This trade represents a 85.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shelagh Glaser sold 7,310 shares of the firm’s stock in a transaction on Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the completion of the transaction, the chief financial officer directly owned 15,291 shares of the company’s stock, valued at approximately $7,427,144.52. This trade represents a 32.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 27,686 shares of company stock valued at $13,001,048. 0.62% of the stock is owned by company insiders.

Synopsys Stock Down 0.5%

SNPS opened at $598.17 on Friday. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a current ratio of 7.02, a quick ratio of 6.85 and a debt-to-equity ratio of 1.01. The stock has a market capitalization of $92.81 billion, a price-to-earnings ratio of 43.19, a P/E/G ratio of 3.95 and a beta of 1.15. The business has a 50 day moving average of $567.73 and a 200-day moving average of $500.38.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.The company had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.60 billion. During the same period in the prior year, the business earned $3.00 earnings per share. Synopsys’s revenue for the quarter was up 10.3% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current year.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.